<code id='111D5BA78E'></code><style id='111D5BA78E'></style>
    • <acronym id='111D5BA78E'></acronym>
      <center id='111D5BA78E'><center id='111D5BA78E'><tfoot id='111D5BA78E'></tfoot></center><abbr id='111D5BA78E'><dir id='111D5BA78E'><tfoot id='111D5BA78E'></tfoot><noframes id='111D5BA78E'>

    • <optgroup id='111D5BA78E'><strike id='111D5BA78E'><sup id='111D5BA78E'></sup></strike><code id='111D5BA78E'></code></optgroup>
        1. <b id='111D5BA78E'><label id='111D5BA78E'><select id='111D5BA78E'><dt id='111D5BA78E'><span id='111D5BA78E'></span></dt></select></label></b><u id='111D5BA78E'></u>
          <i id='111D5BA78E'><strike id='111D5BA78E'><tt id='111D5BA78E'><pre id='111D5BA78E'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:388
          The logo of Department of Justice on a podium — coverage from STAT
          BRENDAN SMIALOWSKI/AFP via Getty Images

          Community Health Systems is facing a new federal probe into its hospital billing practices more than four years after the hospital chain settled separate allegations of fraudulent overbilling.

          CHS, a national system of 71 rural and suburban hospitals, said this week it received a civil investigative demand from the Department of Justice on Jan. 11. Federal investigators asked CHS to hand over documents that covered “practices and procedures related to utilization review, inpatient admissions, and inpatient dialysis at our hospitals.”

          advertisement

          The DOJ initiates these investigations into health care companies when it believes there could be a False Claims Act case, but has not initiated or joined any lawsuits yet.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Inari Medical to buy amputation prevention company LimFlow
          Inari Medical to buy amputation prevention company LimFlow

          Inariwillpay$250millionupfrontand$165moredependingonLimFlow’scommercialsuccess.DavidGregory&Debb

          read more
          United colonoscopy coverage change 'may cost lives,' doctors say
          United colonoscopy coverage change 'may cost lives,' doctors say

          AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

          read more

          STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

          NovoNordiskviaAPWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnew